Table 1

Descriptive statistics of study patients’ demographic and clinical characteristics

N10,870
Age, mean (SD), yearsa59.3 (13.5)
Women, n (%)5,635 (51.8)
Race/ethnicity, n (%)
 White6,447 (59.3)
 Black1,576 (14.5)
 Hispanic1,772 (16.3)
 Asian370 (3.4)
 Otherb705 (6.5)
English as the primary language, n (%)8,623 (79.3)
Health insurance, n (%)
 Private4,336 (39.9)
 Medicare5,162 (47.5)
 Medicaid1,183 (10.9)
 None/unknown189 (1.7)
Median income by zip code, mean (SD), $1000s50.5 (19.5)
No. of hyperglycemic periods, mean (SD)1.3 (0.6)
HbA1c, mean (SD), %; mmol/mol8.3 (1.7); 67 (13.7)
Charlson comorbidity index, mean (SD)6.4 (4.6)
Follow-up time, mean (SD), months82.2 (30.6)
Total time above treatment target, mean (SD), months41.5 (30.7)
  • aAge calculated at the start date of the first hyperglycemic period.

  • bIncludes unknown.